OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Reduced prescription of TNF-inhibitors in chronic arthritis based on therapeutic drug monitoring: A randomized controlled trial
Mogens Pfeiffer‐Jensen, Donghua Liao, Ulrik Tarp, et al.
Scandinavian Journal of Rheumatology (2022) Vol. 52, Iss. 5, pp. 468-480
Open Access | Times Cited: 7
Mogens Pfeiffer‐Jensen, Donghua Liao, Ulrik Tarp, et al.
Scandinavian Journal of Rheumatology (2022) Vol. 52, Iss. 5, pp. 468-480
Open Access | Times Cited: 7
Showing 7 citing articles:
Impact of Chronic Psychological Stress on Cardiovascular Disease Risk: A Narrative Review
Liam Z. Munir, Eugene F. du Toit
Heart and Mind (2024) Vol. 8, Iss. 4, pp. 268-278
Open Access | Times Cited: 1
Liam Z. Munir, Eugene F. du Toit
Heart and Mind (2024) Vol. 8, Iss. 4, pp. 268-278
Open Access | Times Cited: 1
Proactive therapeutic drug monitoring of biologic drugs in patients with inflammatory bowel disease, inflammatory arthritis, and psoriasis: systematic review and meta-analysis
Dena Zeraatkar, Tyler Pitre, Sarah Kirsh, et al.
BMJ Medicine (2024) Vol. 3, Iss. 1, pp. e000998-e000998
Open Access | Times Cited: 1
Dena Zeraatkar, Tyler Pitre, Sarah Kirsh, et al.
BMJ Medicine (2024) Vol. 3, Iss. 1, pp. e000998-e000998
Open Access | Times Cited: 1
Efficacy, safety, and cost-effectiveness of therapeutic drug monitoring (TDM) for TNF inhibitor therapy in rheumatic disease: A systematic review and meta-analysis
Wen‐Liang Dong, Xiaowen Hu, Caiying Wu, et al.
Seminars in Arthritis and Rheumatism (2023) Vol. 63, pp. 152302-152302
Closed Access | Times Cited: 3
Wen‐Liang Dong, Xiaowen Hu, Caiying Wu, et al.
Seminars in Arthritis and Rheumatism (2023) Vol. 63, pp. 152302-152302
Closed Access | Times Cited: 3
Novel insights into the management of rheumatoid arthritis: one year in review 2024
Emanuele Molteni, Antonella Adinolfi, Valentina Bondi, et al.
Clinical and Experimental Rheumatology (2024)
Open Access
Emanuele Molteni, Antonella Adinolfi, Valentina Bondi, et al.
Clinical and Experimental Rheumatology (2024)
Open Access
Adalimumab Therapeutic Drug Monitoring Improves Treatment Outcome in Patients with Psoriasis
Afsáneh Alavi, Edward V. Loftus
Journal of Investigative Dermatology (2023) Vol. 143, Iss. 9, pp. 1625-1628
Open Access | Times Cited: 1
Afsáneh Alavi, Edward V. Loftus
Journal of Investigative Dermatology (2023) Vol. 143, Iss. 9, pp. 1625-1628
Open Access | Times Cited: 1
Comparative study of a point-of-care test and an enzyme-linked immunosorbent assay (ELISA) for infliximab levels
Joel Thunberg, Olle Grännö, Daniel Bergemalm, et al.
Scandinavian Journal of Gastroenterology (2023) Vol. 59, Iss. 2, pp. 150-155
Open Access | Times Cited: 1
Joel Thunberg, Olle Grännö, Daniel Bergemalm, et al.
Scandinavian Journal of Gastroenterology (2023) Vol. 59, Iss. 2, pp. 150-155
Open Access | Times Cited: 1
Rheumatology patients on immunosuppressive treatment and their perioperative management: Review of recommendations
S Gulam Khader, Wajith Hussain Zahir Hussain, Arumugam Moorthy
Musculoskeletal Care (2022) Vol. 21, Iss. 2, pp. 571-575
Open Access
S Gulam Khader, Wajith Hussain Zahir Hussain, Arumugam Moorthy
Musculoskeletal Care (2022) Vol. 21, Iss. 2, pp. 571-575
Open Access
